Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Exchange Rate Effect (2023 - 2025)

Arcutis Biotherapeutics has reported Exchange Rate Effect over the past 3 years, most recently at $59000.0 for Q4 2025.

  • Quarterly results put Exchange Rate Effect at $59000.0 for Q4 2025, up 125.21% from a year ago — trailing twelve months through Dec 2025 was $168000.0 (up 171.49% YoY), and the annual figure for FY2025 was $168000.0, up 171.49%.
  • Exchange Rate Effect for Q4 2025 was $59000.0 at Arcutis Biotherapeutics, up from -$95000.0 in the prior quarter.
  • Over the last five years, Exchange Rate Effect for ARQT hit a ceiling of $200000.0 in Q2 2025 and a floor of -$234000.0 in Q4 2024.
  • Median Exchange Rate Effect over the past 3 years was -$11000.0 (2024), compared with a mean of -$9750.0.
  • Biggest five-year swings in Exchange Rate Effect: crashed 444.12% in 2024 and later soared 869.23% in 2025.
  • Arcutis Biotherapeutics' Exchange Rate Effect stood at $68000.0 in 2023, then crashed by 444.12% to -$234000.0 in 2024, then skyrocketed by 125.21% to $59000.0 in 2025.
  • The last three reported values for Exchange Rate Effect were $59000.0 (Q4 2025), -$95000.0 (Q3 2025), and $200000.0 (Q2 2025) per Business Quant data.